Chardan Capital Still Positive on Rockwell Medical (RMTI) Following Q3 Results, Update

Go back to Chardan Capital Still Positive on Rockwell Medical (RMTI) Following Q3 Results, Update

Rockwell Medical Technologies (RMTI) Reports In-Line Q3 Loss

November 10, 2014 4:02 PM EST

Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $13.7 million versus the consensus estimate of $13.4 million.

"We achieved a strong 3rd quarter and then two significant accomplishments; our successful confirmatory vote... More